Cytotoxic and cytoskeletal effects of azaspiracid-1 on mammalian cell lines

Toxicon. 2005 Jun 1;45(7):891-900. doi: 10.1016/j.toxicon.2005.02.015. Epub 2005 Apr 18.

Abstract

Azaspiracid-1 (AZA-1) is a newly identified phycotoxin reported to accumulate in molluscs from several northern European countries and documented to have caused severe human intoxications. The mechanism of action of AZA-1 is unknown. Our initial investigations have shown that AZA-1 is cytotoxic to a range of cell types. Cytotoxicity was evident in all seven cell types tested, suggesting a broad-spectrum mode of action, and was both time- and concentration-dependent. However, AZA-1 took an unusually long time (>24 h) to cause complete cytotoxicity in most cell types, with the exception of the rat pituitary GH(4)C(1). Extended exposure times did not always lower the EC(50) value for a given cell line, but always resulted in more complete cytotoxicity over a very narrow concentration range. The Jurkat cell line (human lymphocyte T) appeared to be very sensitive to AZA-1, although the EC(50) values (24-72 h) for all the cell types were in the low nanomolar range (0.9-16.8 nM). The effect of AZA-1 on membrane integrity was tested on Jurkat cells and these data confirm our visual observations of cytotoxicity and necrotic cell lysis following exposure of Jurkat cells to AZA-1 and suggest that AZA-1 has some properties unique among marine algal toxins. Additionally, there were dramatic effects of AZA-1 on the arrangement of F-actin with the concurrent loss of pseudopodia, cytoplasmic extensions that function in mobility and chemotaxis. Although these phycotoxin-specific effects of AZA-1 suggest a possible site of action, further work using cell-based approaches is needed to determine the precise mode of action of AZA-1.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Animals
  • Bivalvia / chemistry
  • Cell Line
  • Cell Survival / drug effects*
  • Cytoskeleton / drug effects
  • Cytoskeleton / pathology
  • Humans
  • Jurkat Cells
  • Marine Toxins / toxicity*
  • Phosphoprotein Phosphatases / antagonists & inhibitors
  • Phosphoprotein Phosphatases / metabolism
  • Pseudopodia / drug effects*
  • Pseudopodia / pathology
  • Spiro Compounds / toxicity*

Substances

  • Actins
  • Marine Toxins
  • Spiro Compounds
  • azaspiracid
  • Phosphoprotein Phosphatases